DK464478A - Fremgangsmaade til fremstilling af 3-substituerede 6-(1'hydroxyethyl)-m-oxo-1-azabicyclo(3,2,0)hept-2-en-2-carboxylsyrer eller derivater deraf - Google Patents

Fremgangsmaade til fremstilling af 3-substituerede 6-(1'hydroxyethyl)-m-oxo-1-azabicyclo(3,2,0)hept-2-en-2-carboxylsyrer eller derivater deraf

Info

Publication number
DK464478A
DK464478A DK464478A DK464478A DK464478A DK 464478 A DK464478 A DK 464478A DK 464478 A DK464478 A DK 464478A DK 464478 A DK464478 A DK 464478A DK 464478 A DK464478 A DK 464478A
Authority
DK
Denmark
Prior art keywords
azabicyclo
hept
oxo
hydroxyethyl
derivatives
Prior art date
Application number
DK464478A
Other languages
English (en)
Inventor
B G Christensen
D B R Johnston
S M Schmitt
Original Assignee
Merck & Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck & Co Inc filed Critical Merck & Co Inc
Publication of DK464478A publication Critical patent/DK464478A/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/26Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 4
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/39Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups
    • C07C205/42Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by esterified hydroxy groups having nitro groups or esterified hydroxy groups bound to carbon atoms of six-membered aromatic rings of the carbon skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D205/00Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/06Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D205/08Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with one oxygen atom directly attached in position 2, e.g. beta-lactams
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D477/00Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring
    • C07D477/10Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2
    • C07D477/12Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6
    • C07D477/16Heterocyclic compounds containing 1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula:, e.g. carbapenicillins, thienamycins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulphur-containing hetero ring with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 4, and with a carbon atom having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 2 with hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, attached in position 6 with hetero atoms or carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. an ester or nitrile radical, directly attached in position 3
    • C07D477/20Sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/10Compounds having one or more C—Si linkages containing nitrogen having a Si-N linkage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
DK464478A 1977-10-19 1978-10-18 Fremgangsmaade til fremstilling af 3-substituerede 6-(1'hydroxyethyl)-m-oxo-1-azabicyclo(3,2,0)hept-2-en-2-carboxylsyrer eller derivater deraf DK464478A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US84337577A 1977-10-19 1977-10-19

Publications (1)

Publication Number Publication Date
DK464478A true DK464478A (da) 1979-04-20

Family

ID=25289786

Family Applications (1)

Application Number Title Priority Date Filing Date
DK464478A DK464478A (da) 1977-10-19 1978-10-18 Fremgangsmaade til fremstilling af 3-substituerede 6-(1'hydroxyethyl)-m-oxo-1-azabicyclo(3,2,0)hept-2-en-2-carboxylsyrer eller derivater deraf

Country Status (8)

Country Link
EP (1) EP0001627B1 (da)
JP (1) JPS5466696A (da)
AU (1) AU4061378A (da)
DE (1) DE2862395D1 (da)
DK (1) DK464478A (da)
ES (1) ES474289A1 (da)
IT (1) IT1110867B (da)
ZA (1) ZA785857B (da)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives
EP0008888B1 (en) * 1978-08-23 1983-09-21 Beecham Group Plc Beta-lactam antibacterial compounds, their preparation and pharmaceutical compositions containing them
EP0008514B1 (en) * 1978-08-25 1982-01-20 Beecham Group Plc Beta-lactam anti-bacterials, compositions containing them and a process for their preparation
EP0011173B1 (en) * 1978-11-01 1983-05-11 Sanraku-Ocean Co., Ltd. Process for producing antibiotic beta-lactam compounds
EP0082133A3 (en) * 1979-04-19 1983-07-20 Merck & Co. Inc. A process for preparing intermediates useful for preparing 2-substituted-6-substituted-1-carbadethiapen-2-em-3-carboxylic acids
US4376774A (en) * 1979-05-29 1983-03-15 Merck & Co., Inc. Antibiotic N-heterocyclyl thienamycin
JPS565457A (en) * 1979-06-27 1981-01-20 Dai Ichi Seiyaku Co Ltd Thienamycin intermediate
EP0055990B1 (en) * 1979-08-10 1986-06-11 Beecham Group Plc Beta-lactam antibiotics, their preparation and use
ATE10838T1 (de) * 1980-02-28 1985-01-15 Fujisawa Pharmaceutical Co., Ltd. 4-substituierte 2-oxoazetidin-verbindungen, verfahren zu deren herstellung und ihre verwendung zur antibiotika-herstellung.
US4309346A (en) * 1980-03-27 1982-01-05 Merck & Co., Inc. Process for the preparation of 1-carbapenems and intermediates via trithioorthoacetates
PT73791B (en) * 1980-10-17 1983-10-14 Merck & Co Inc Process for preparing 2-carbamimidoyl-6-substituted-1- -carbadethiapen-2-em-3-carboxylic acids
EP0050927B1 (en) * 1980-10-25 1985-03-27 Beecham Group Plc The preparation of beta-lactam antibiotics
JPS57103057A (en) * 1980-12-19 1982-06-26 Meito Sangyo Kk Automatic measuring method for hdl-cholesterol and its precipitant
US4552873A (en) * 1981-08-19 1985-11-12 Sankyo Company Limited Carbapenem compounds, and compositions containing them
JPS5865291A (ja) * 1981-10-14 1983-04-18 Sankyo Co Ltd カルバペネム−3−カルボン酸誘導体およびその製法
EP0079167A1 (en) * 1981-11-09 1983-05-18 Beecham Group Plc A carbapenem compound, preparation and use
US4683301A (en) * 1982-04-08 1987-07-28 Bristol-Myers Company Carbapenem antibiotics
US4642341A (en) * 1982-04-09 1987-02-10 Bristol-Myers Company Carbapenem antibiotics
US4710568A (en) * 1982-04-09 1987-12-01 Bristol-Myers Company Carbapenem antibiotics
US4493839A (en) * 1982-05-24 1985-01-15 Merck & Co., Inc. 1-Carbapenem-3-carboxylic esters as anti-inflammatory agents
US4536335A (en) * 1982-06-18 1985-08-20 Bristol-Myers Company Carbapenem antibiotics
US4665170A (en) * 1982-06-18 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
US4640799A (en) * 1982-06-18 1987-02-03 Bristol-Myers Company Carbapenem antibiotics
US4732977A (en) * 1982-09-28 1988-03-22 Bristol Myers Company Carbapenem antibiotics
US4746736A (en) * 1982-09-28 1988-05-24 Bristol-Myers Company Carbapenem antibiotics
US4665169A (en) * 1985-09-11 1987-05-12 Bristol-Myers Company Carbapenem antibiotics
WO2010150548A1 (ja) * 2009-06-26 2010-12-29 イハラケミカル工業株式会社 ケトマロン酸化合物又はその抱水体の製造法
KR102134407B1 (ko) * 2014-02-17 2020-07-15 구미아이 가가쿠 고교 가부시키가이샤 유통 반응기를 사용한 케토말론산 화합물의 연속 제조방법

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3950357A (en) * 1974-11-25 1976-04-13 Merck & Co., Inc. Antibiotics
NL7612937A (nl) * 1975-11-21 1977-05-24 Merck & Co Inc Thienamycinederivaten en farmaceutische prepa- raten alsmede werkwijze voor het bereiden daarvan.
JPS5283992A (en) * 1976-01-01 1977-07-13 Beecham Group Ltd Novel antibiotic
NL7712093A (nl) * 1976-11-19 1978-05-23 Merck & Co Inc Werkwijze voor het bereiden van isomere thienamycinen.
GB1593524A (en) * 1976-11-19 1981-07-15 Merck & Co Inc 1-carba-2-penem-3-carboxylic acids
AU531084B2 (en) * 1977-10-19 1983-08-11 Merck & Co., Inc. Azetidine derivatives

Also Published As

Publication number Publication date
AU4061378A (en) 1980-04-17
IT1110867B (it) 1986-01-06
JPS5466696A (en) 1979-05-29
JPH0438753B2 (da) 1992-06-25
ZA785857B (en) 1980-06-25
ES474289A1 (es) 1979-11-01
DE2862395D1 (en) 1984-05-10
EP0001627B1 (en) 1984-04-04
EP0001627A1 (en) 1979-05-02
IT7851566A0 (it) 1978-10-18

Similar Documents

Publication Publication Date Title
DK464478A (da) Fremgangsmaade til fremstilling af 3-substituerede 6-(1'hydroxyethyl)-m-oxo-1-azabicyclo(3,2,0)hept-2-en-2-carboxylsyrer eller derivater deraf
DK464578A (da) Fremgangsmaade til fremstilling af 3-substituerede og 6-substituerede 7-oxo-1-azabicyclo (3,2,0) hept-2-en-2-carxylsyrer eller amiier deraf
DK15279A (da) Fremgangsmaade til fremstilling af tetrahydropyridinylindolderivater eller additionssalte deraf
DK148260C (da) Analogifremgangsmaade til fremstilling af 1,3,8-trisubstituerede xantinderivater eller salte deraf
DK258078A (da) Fremgangsmaade til fremstilling af 7alfa-methoxy-7beta-(1,3-dithiethan-2-carboxamido) cephalosporansyre-derivater
DK372380A (da) Fremgangsmaade til fremstilling af 5,6,7-trinor4,8-inter-m-phemylen pgi2 derivater
DK142180A (da) Fremgangsmaade til fremstilling af 6-substituerede pyranon-derivater
DK13978A (da) Fremgangsmaade til fremstilling af 11betasubstituerede 1,3,5(,0)-triensteroider
DK118578A (da) Fr&mgangsmaade til fremstilling af pyridinylaminoalkylethere,n-oxider eller physiologisk acceptable syreadditionssalte deraf
DK260579A (da) Fremgangsmaade til fremstilling af 14,15-methylenderivater af oestranraekken
DK129678A (da) Fremgangsmaade til fremstilling af oximderivater af 7-aminothiazolylacetamidocephalosporansyre
DK75878A (da) Fremgangsmaade til fremstilling af 20,21,-di-noreburnameninderivater eller additionssalte deraf
DK382979A (da) Fremgangsmaade til fremstilling af 3" , 4"-diacyltylosinderivater
DK148538C (da) Analogifremgangsmaade til fremstilling af 2,3-substituerede 4-pyroner
DK173379A (da) Fremgangsmaade til fremstilling af 6alfa-halogen-3-keto-delta 1,4-pregnadienderivater
AR216558A1 (es) Procedimiento de preparacion de 1,3-dihidro-3-(3',4',5'-trimetoxi-estiril)-6-metil-7-hidroxi-furo-(3,4,c)-piridina
DK190378A (da) Fremgangsmaade til fremstilling af benzimidazolderivater
DK142080A (da) Fremgangsmaade til fremstilling af 6-substituerede pyranon-derivater
DK148302C (da) Analogifremgangsmaade til fremstilling af 1,3-dialkylxanthinderivater
DK113483D0 (da) Fremgangsmade til fremstilling af 3,4-diphenyl-5-methylpyrazolderivater
SE7700533L (sv) Forfarande for framstellning av 3,4-dihydro-2(1h)-kinazolinonderivat
DK57778A (da) Fremgangsmaade til fremstilling af 1,3-disubstitueret urinstof eller 2-thioruinstof
FI782517A (fi) Foerfarande foer framstaellning av 2,3-polymetylen-4-oxo-4h-pyrido(1,2-a)-pyrimidiner
NO781928L (no) Fremgangsmaate til fremstilling av guanidinderivater
MX5020E (es) Procedimiento de preparacion de derivados de tieno (2,3,-c)y tieno (3,2,c)piridinas